Drugmaker to pay $1.4B in largest US opioid treatment settlement
Reckitt Benckiser Group has agreed to pay up to $1.4 billion to resolve a long-running United States federal investigation into the company's sales and marketing of Suboxone, a prescription drug used to treat people addicted to heroin, painkillers and other opioids.